CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,014 | +4.4% | 600 | +20.0% | 0.00% | – |
| Q2 2023 | $6,720 | +102.7% | 500 | +150.0% | 0.00% | – |
| Q1 2023 | $3,316 | +122.8% | 200 | +150.0% | 0.00% | – |
| Q4 2022 | $1,488 | +48.8% | 80 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -100.0% | 80 | -98.5% | 0.00% | – |
| Q1 2021 | $23,972,000 | +266255.6% | 5,200 | +108.0% | 0.00% | – |
| Q4 2019 | $9,000 | -60.9% | 2,500 | -44.4% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | +155.6% | 4,500 | +80.0% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |